Paraneoplastic Sweet's syndrome and the pathergy phenomenon

Ann Hematol. 2007 Aug;86(8):613-4. doi: 10.1007/s00277-007-0279-5. Epub 2007 Apr 28.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Antineoplastic Combined Chemotherapy Protocols / adverse effects
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use
  • Cytarabine / adverse effects*
  • Cytarabine / therapeutic use
  • Diagnosis, Differential
  • Drug Eruptions / diagnosis
  • Etoposide / adverse effects*
  • Etoposide / therapeutic use
  • Female
  • Humans
  • Inflammation / diagnosis
  • Leukemia, Monocytic, Acute / complications*
  • Leukemia, Monocytic, Acute / drug therapy
  • Middle Aged
  • Mitoxantrone / adverse effects*
  • Mitoxantrone / therapeutic use
  • Neutropenia / etiology
  • Paraneoplastic Syndromes / diagnosis
  • Paraneoplastic Syndromes / drug therapy
  • Paraneoplastic Syndromes / etiology
  • Sweet Syndrome / diagnosis
  • Sweet Syndrome / drug therapy
  • Sweet Syndrome / etiology*

Substances

  • Cytarabine
  • Etoposide
  • Mitoxantrone